Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03560934Phase 1Completed
Phase 1, randomised, double-blind trial of dronabinol in sleep disorder, sponsored by Oregon Health & Science University. Primary endpoint: Sleep Stages. Started Sep 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03560934.